Log In
Print
BCIQ
Print
Print this Print this
 

AZD2098

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCC chemokine receptor 4 (CCR4; CD194) antagonist
Molecular Target CC chemokine receptor 4 (CCR4) (CD194)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal cancer
Indication DetailsTreat kidney cancer
Regulatory Designation

Partner

Cancer Research Technology Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today